6:06 PM
 | 
Apr 16, 2012
 |  BC Extra  |  Financial News

Vivia receives loans, equity totaling EUR 7.2 million

Cancer company Vivia Biotech S.L. (Madrid, Spain) received EUR 6 million ($7.8 million) in loans from the Multiinstrument...

Read the full 73 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >